Abbott
779
37
58
558
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
10.8%
84 terminated/withdrawn out of 779 trials
86.9%
+0.4% vs industry average
38%
299 trials in Phase 3/4
35%
196 of 558 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (779)
A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease
Role: collaborator
Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction
Role: collaborator
Arrhythmia Detection After MI
Role: collaborator
Optical Coherence Tomography in Acute Vessel Evaluation
Role: collaborator
Subthalamic Steering for Therapy Optimization in Parkinson's Disease
Role: collaborator
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
Role: collaborator
PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Intervention - Study
Role: collaborator
Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics
Role: collaborator
The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)
Role: collaborator
Virtual E-health System for Pacemakers
Role: collaborator
Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With Non-Obstructive Coronary Arteries
Role: collaborator
Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy
Role: collaborator
Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood Pumps
Role: collaborator
Combating Related Epidemics in HCV
Role: collaborator
Continuous Glucose Monitoring (CGM) in an Underserved Population
Role: collaborator
Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK).
Role: collaborator
Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillation - Trigger and Substrate Guided Wide Area Radiofrequency Ablation Compared to Pulsed Field Ablation Pulmonary Vein Isolation
Role: collaborator
Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting
Role: collaborator
Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing
Role: collaborator
Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)
Role: collaborator